Resmed Inc Drc Stock Price To Earnings To Growth
RSMDFDelisted Stock | USD 17.70 0.00 0.00% |
Resmed Inc DRC fundamentals help investors to digest information that contributes to Resmed's financial success or failures. It also enables traders to predict the movement of Resmed Pink Sheet. The fundamental analysis module provides a way to measure Resmed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Resmed pink sheet.
Resmed |
Resmed Inc DRC Company Price To Earnings To Growth Analysis
Resmed's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Current Resmed Price To Earnings To Growth | 1.76 X |
Most of Resmed's fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Resmed Inc DRC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
CompetitionBased on the latest financial disclosure, Resmed Inc DRC has a Price To Earnings To Growth of 1.762 times. This is 148.17% higher than that of the Healthcare sector and notably lower than that of the Medical Instruments & Supplies industry. The price to earnings to growth for all United States stocks is 63.97% higher than that of the company.
Resmed Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Resmed's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Resmed could also be used in its relative valuation, which is a method of valuing Resmed by comparing valuation metrics of similar companies.Resmed is currently under evaluation in price to earnings to growth category among its peers.
Resmed Fundamentals
Return On Equity | 0.24 | |||
Return On Asset | 0.12 | |||
Profit Margin | 0.22 % | |||
Operating Margin | 0.28 % | |||
Current Valuation | 33.08 B | |||
Shares Outstanding | 1.47 B | |||
Shares Owned By Institutions | 7.93 % | |||
Price To Earning | 28.58 X | |||
Price To Book | 9.54 X | |||
Price To Sales | 9.04 X | |||
Revenue | 3.58 B | |||
Gross Profit | 2.06 B | |||
EBITDA | 1.18 B | |||
Net Income | 779.44 M | |||
Cash And Equivalents | 273.71 M | |||
Cash Per Share | 0.47 X | |||
Total Debt | 765.33 M | |||
Debt To Equity | 0.27 % | |||
Current Ratio | 2.80 X | |||
Book Value Per Share | 6.36 X | |||
Cash Flow From Operations | 351.15 M | |||
Earnings Per Share | 0.55 X | |||
Price To Earnings To Growth | 1.76 X | |||
Target Price | 11.49 | |||
Number Of Employees | 8.16 K | |||
Beta | 0.47 | |||
Market Capitalization | 34.16 B | |||
Total Asset | 5.1 M | |||
Annual Yield | 0.01 % | |||
Net Asset | 5.1 M | |||
Last Dividend Paid | 1.72 |
About Resmed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Resmed Inc DRC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Resmed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Resmed Inc DRC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Resmed Pink Sheet
If you are still planning to invest in Resmed Inc DRC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Resmed's history and understand the potential risks before investing.
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |